University of Washington - Harborview Medical Center
University of Washington - Harborview Medical Center
Seattle, Washington, United States8 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of Brenipatide in Participants With Opioid Use Disorder | Chemically-Induced Disorders, Narcotic-Related Disorders, Opioid Use Disorder, opiate dependence, psychiatric disorder, substance-related disorder | Recruiting | Phase 2 | 2026-10-07 | NCT07420283 | |
| A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older | Clostridoides Difficile Associated Disease | Recruiting | Phase 3 | 2026-09-09 | NCT07282665 | |
| The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms | Aneurysm, Bites and Stings, Chemically-Induced Disorders, Fusiform Aneurysm, Saccular Aneurysm, brain aneurysm, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, hemorrhagic stroke, injury, intracranial arterial disease, nervous system disorder, poisoning, stroke disorder, vascular disorder | Recruiting | Not applicable | 2026-09-09 | NCT07143019 | |
| A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) | Cholangitis, Sclerosing, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, primary sclerosing cholangitis, skin disorder | Active, not recruiting | Phase 2 | 2026-08-26 | NCT04663308 | |
| A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid, brain disorder, central nervous system disorder, cognitive disorder, dementia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Phase 3 | 2026-08-26 | NCT04437511 | |
| Stroke and CPAP Outcome Study 3 Randomized Controlled Trial | Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder | Recruiting | Not applicable | 2026-08-13 | NCT06722755 | |
| Enhancing Rehabilitation Participation in Patients With SCI/D Using Motivational Interviewing | central nervous system disorder, injury, nervous system disorder, nervous system injury, spinal cord disorder, spinal cord injury | Recruiting | Not applicable | 2026-01-23 | NCT07364773 | |
| Effects of Semaglutide on Intracranial Blood Flow and Brain-Barrier Permeability in Type-2 Diabetes | Nutritional and Metabolic Diseases, brain disorder, brain ischemia, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, nervous system disorder, stroke disorder, transient ischemic attack, type 2 diabetes mellitus, vascular disorder | Recruiting | Phase 4 | 2024-06-05 | NCT05780905 |